Bone-building drug coming for post-menopause women
Abaloparatide protects against the bone-thinning condition osteoporosis and is approved for NHS use.
Abaloparatide protects against the bone-thinning condition osteoporosis and is approved for NHS use.
Revenues increased 45% compared to the previous quarter ended March 31, 2024 Optimized LungFit PH...
$350 Million in Contract Awards in Q2; $89 Million in Contract Awards Post-Q2 Q2 Adjusted...
Q1 Financial Highlights: Revenue Increased Over 33% Year Over Year to $40 Million...
RESTON, Va.–(BUSINESS WIRE)–Bowman Consulting Group Ltd. (Nasdaq: BWMN) (Bowman or the Company), a national engineering...
By Ankur Banerjee SINGAPORE (Reuters) – The dollar was steady on Wednesday, dragging the yen...
By Leika Kihara HAKODATE, Japan (Reuters) -Bank of Japan (BOJ) Deputy Governor Shinichi Uchida said...
— Advancing four clinical-stage programs for hematologic malignancies and autoimmune diseases; clinical data reports planned...
SAN FRANCISCO, Aug. 6, 2024 /PRNewswire/ — Instacart (NASDAQ: CART) today released financial results for...